Adjuvant chemotherapy & trastuzumab for HER2-positive early invasive breast cancer

Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England

Melissa Ruth Gannon, David Dodwell, Yasmin Jauhari, Kieran Horgan, Karen Clements, Jibby Medina, David Alan Cromwell

Published: June 1, 2020. Journal of Geriatric Oncology 11(5):836-842

View the Journal